Depression Esketamine Ketamine

5,237 viewsMay 23, 2019, 12:05am

Study Finds Ketamine Nasal Spray Effective For Treating Depression: What You Should Know

ASSOCIATED PRESS

A new study finds that a nasal spray formulated from the anesthetic ketamine is a safe, fast-acting and effective treatment for treatment-resistant depression. Researchers presented the findings this week at the annual meeting of the American Psychiatric Association.

Esketamine, the intranasal formulation of ketamine, recently received FDA approval as a depression treatment when used with an oral antidepressant, based in part on findings from this study. The results open the door to a potential new alternative for the estimated 30% of depression patients suffering from treatment-resistant depression.

The study included 197 adults from 39 outpatient centers over a two-year period. All of the participants had either moderate or severe depression and hadn’t responded well to at least two antidepressants in the past. Participants were randomly assigned to one of two groups: The first switched from their current antidepressant treatment to esketamine nasal spray and a new oral antidepressant; the other switched from their current treatment to a placebo nasal spray and a new antidepressant.

The results showed significant improvements in depression symptoms among those in the esketamine group compared to the placebo group four weeks into the study, with signs of improvement starting much earlier.

“The study supports the efficacy and safety of esketamine nasal spray as a rapidly acting antidepressant for patients with treatment-resistant depression,” the study concluded.

“Not only was adjunctive esketamine therapy effective, the improvement was evident within the first 24 hours,” said Michael Thase, M.D., one of the study authors. “The novel mechanism of action of esketamine, coupled with the rapidity of benefit, underpins just how important this development is for patients with difficult-to-treat depression.”

20 Jun, 2019

Loudoun County Ketamine 703-844-0184 | NOVA Health Recovery | Ketamine for depression and PTSD | Nudexta – dextromethorphan and quinidine for depression | Spravato Center | Spravato Northern Virginia | nasal spray Ketamine Center Alexandria, Va

NOVA Health Recovery | Alexandria, Va 22306 | Call for esketamine and nasal ketamine as well as IV Ketamine for depression, PTSD, anxiety  703-844-0184 < Link Dextromethorphan-quinidine-pharmacotherapy-in-patients-with-treatment-resistant-depressionDownload The-utility-of-the-combination-of-dextromethorphan-and-quinidine-in-the-treatment-of-bipolar-II-and-bipolar-NOSDownload Dextromethorphan/quinidine pharmacotherapy in patients… Read More
11 Mar, 2019

Ketamine Infusion Center | 703-844-0184 | NOVA Health Recovery | Alexandria, Va 22306 | Inhaled Ketamine in the news |22102 22207 | Arlington Ketamine Center | Dr. Sendi

Call NOVA Health Recovery at 703-844-0184 for a free consultation for a Ketamine infusion. No referral needed. We offer intranasal Ketamine follow up therapy as well. https://www.youtube.com/watch?v=9vbeAQhEJPQ https://www.cnn.com/videos/health/2019/03/06/fda-approves-nasal-spray-antidepressant-spravato-gupta-pkg-newday-vpx.cnn Read More
CALL US
Consultation